Welcome back to the third blog on US COVID-19 vaccines. Since October, two sponsors, Moderna and BioN/Pfizer, have filed for Emergency Use Authorization (EUA) in the US, the latter was approved in the UK. Though more is now known about the efficacy, which looks great so far (see chart), more will be known about short-term side effects over the next two weeks as review meetings are set to take place Dec. 10th and 17th. Data results for the three remaining agents, sponsored by Astra Zeneca,...